Takasaki, A., Tamura, H., Miwa, I., Taketani, T., Shimamura, K., Sugino, N., 2010
Start your intake Zepbound explained: tirzepatide under a weight-management label Zepbound is a brand name for tirzepatide, a GIP and GLP-1 dual receptor agonist, marketed as an FDA-approved product for weight management
Orforglipron's unrestricted oral dosing and demonstrated superiority over oral semaglutide in ACHIEVE-3 position it as the preferred oral GLP-1 option for many patients
Your healthcare provider or dietitian can help you devise an appropriate meal plan and exercise regimen
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
If you're spending an hour a day on the treadmill but never picking up anything heavier than your water bottle, your GLP-1 is eating your muscle and your exercise program isn't doing anything to stop it